199 related articles for article (PubMed ID: 29512830)
1. Tumor-stage mycosis fungoides in palmoplantar localization with large-cell transformation and partial CD30 expression shows complete response to brentuximab vedotin.
Pham AK; Carter JB; Ratcliffe NR; Fuld AD; Lansigan F; Burnside NJ; Guill MA; Zug KA; Jarvis LA; LeBlanc RE
J Cutan Pathol; 2018 Jun; 45(6):458-462. PubMed ID: 29512830
[TBL] [Abstract][Full Text] [Related]
2. Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.
Kim YH; Tavallaee M; Sundram U; Salva KA; Wood GS; Li S; Rozati S; Nagpal S; Krathen M; Reddy S; Hoppe RT; Nguyen-Lin A; Weng WK; Armstrong R; Pulitzer M; Advani RH; Horwitz SM
J Clin Oncol; 2015 Nov; 33(32):3750-8. PubMed ID: 26195720
[TBL] [Abstract][Full Text] [Related]
3. Impressive response of CD30-negative, treatment-refractory mycosis fungoides to brentuximab vedotin.
Goyal A; Hordinsky M; Lazaryan A
Dermatol Ther; 2019 Mar; 32(2):e12835. PubMed ID: 30659762
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features and T-cell receptor gene rearrangement findings of mycosis fungoides palmaris et plantaris.
Kim ST; Jeon YS; Sim HJ; Kim SH; Kim YK; Suh KS; Park JH; Park SW
J Am Acad Dermatol; 2006 Mar; 54(3):466-71. PubMed ID: 16488298
[TBL] [Abstract][Full Text] [Related]
5. Mycosis fungoides palmaris et plantaris successfully treated with radiotherapy: case report and mini-review of the published work.
Nakai N; Hagura A; Yamazato S; Katoh N
J Dermatol; 2014 Jan; 41(1):63-7. PubMed ID: 24438146
[TBL] [Abstract][Full Text] [Related]
6. Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome.
Mehra T; Ikenberg K; Moos RM; Benz R; Nair G; Schanz U; Haralambieva E; Hoetzenecker W; Dummer R; French LE; Guenova E; Cozzio A
JAMA Dermatol; 2015 Jan; 151(1):73-7. PubMed ID: 25317818
[TBL] [Abstract][Full Text] [Related]
7. Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis.
Kim YH; Prince HM; Whittaker S; Horwitz SM; Duvic M; Bechter O; Sanches JA; Stadler R; Scarisbrick J; Quaglino P; Zinzani PL; Wolter P; Eradat H; Pinter-Brown LC; Ortiz-Romero PL; Akilov OE; Trotman J; Taylor K; Weichenthal M; Walewski J; Fisher D; McNeeley M; Gru AA; Brown L; Palanca-Wessels MC; Lisano J; Onsum M; Bunn V; Little M; Trepicchio WL; Dummer R
Eur J Cancer; 2021 May; 148():411-421. PubMed ID: 33794441
[TBL] [Abstract][Full Text] [Related]
8. Poikilodermatous mycosis fungoides with CD30-positive large cell transformation successfully treated by brentuximab vedotin.
Popadic S; Lekic B; Tanasilovic S; Bosic M; Nikolic M
Dermatol Ther; 2020 Jan; 33(1):e13152. PubMed ID: 31743946
[TBL] [Abstract][Full Text] [Related]
9. Mycosis Fungoides Palmaris et Plantaris on the Plantar Aspect of the Foot: A Case Report.
Beiser I; Yim J; Robles-Sherman E; Mirkin GS; Hao X
Am J Case Rep; 2020 Sep; 21():e923361. PubMed ID: 32943601
[TBL] [Abstract][Full Text] [Related]
10. Multiple plaques on the hands and feet. Mycosis fungoides (MF) palmaris et plantaris (MFPP).
Lambert TJ; Prieto VG; Duvic M
Arch Dermatol; 2007 Jan; 143(1):109-14. PubMed ID: 17224554
[No Abstract] [Full Text] [Related]
11. Transformation of mycosis fungoides: T-cell receptor beta gene analysis demonstrates a common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma.
Wood GS; Bahler DW; Hoppe RT; Warnke RA; Sklar JL; Levy R
J Invest Dermatol; 1993 Sep; 101(3):296-300. PubMed ID: 8396607
[TBL] [Abstract][Full Text] [Related]
12. Acral erosive mycosis fungoides: successful treatment with localised radiotherapy.
Wang CM; Duvic M; Dabaja BS
BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23595169
[TBL] [Abstract][Full Text] [Related]
13. Mycosis fungoides palmaris et plantaris.
Resnik KS; Kantor GR; Lessin SR; Kadin ME; Chooback L; Cooper HS; Vonderheid EC
Arch Dermatol; 1995 Sep; 131(9):1052-6. PubMed ID: 7661607
[TBL] [Abstract][Full Text] [Related]
14. Large cell transformation mimicking regional lymphomatoid papulosis in a patient with mycosis fungoides.
Nakahigashi K; Ishida Y; Matsumura Y; Kore-Eda S; Ohmori K; Fujimoto M; Yamashita K; Kotani H; Sakurai T; Miyachi Y
J Dermatol; 2008 May; 35(5):283-8. PubMed ID: 18477228
[TBL] [Abstract][Full Text] [Related]
15. Hypopigmented Mycosis Fungoides with Large Cell Transformation in a Child.
Pradhan D; Jedrych JJ; Ho J; Akilov OE
Pediatr Dermatol; 2017 Sep; 34(5):e260-e264. PubMed ID: 28804923
[TBL] [Abstract][Full Text] [Related]
16. Mycosis fungoides with focal CD 30 transformation in an adolescent.
Romero M; Haney M; Desantis E; Zlotoff B
Pediatr Dermatol; 2008; 25(5):565-8. PubMed ID: 18950403
[TBL] [Abstract][Full Text] [Related]
17. Treatment of CD30-Negative Refractory Mycosis Fungoides With Brentuximab Vedotin.
Zhang C; Chairatchaneeboon M; Haun P; Landsburg D; Kim EJ
JAMA Dermatol; 2018 Jan; 154(1):109-110. PubMed ID: 29167875
[No Abstract] [Full Text] [Related]
18. [Mycosis fungoides palmaris et plantaris].
Pfaff S; Megahed M
Hautarzt; 2012 Dec; 63(12):920-3. PubMed ID: 23111567
[TBL] [Abstract][Full Text] [Related]
19. Disease characteristics, prognosis, and response to therapy in patients with large-cell transformed mycosis fungoides: A single-center retrospective study.
O'Donnell M; Zaya R; Correia E; Krishnasamy S; Sahu J; Shi W; Cha J; Alpdogan SO; Porcu P; Nikbakht N
J Am Acad Dermatol; 2022 Jun; 86(6):1285-1292. PubMed ID: 34273458
[TBL] [Abstract][Full Text] [Related]
20. [Management of mycosis fungoide : focus on brentuximab vedotin].
Lebas E; Collins P; Bonnet C; Libon F; Dezfoulian B; Nikkels AF
Rev Med Liege; 2021 Apr; 76(4):224-231. PubMed ID: 33830684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
